Choice of treatment for menor rhagia

Abstract

First and foremost, medical management has a definite place. [...]increasing experience (including some small randomised trials7–10) of the levonorgestrel-releasing intrauterine device suggests that it and its successors will have a useful therapeutic role. 12 This supplemented advice given in March, 1998, of reports of perforation of the uterine wall and injury to adjacent organs.13 The Aberdeen Endometrial Ablation Trials Group has recently reported the results of the 4-year follow-up of patients in their randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional bleeding.3 151 (74%) of the 204 women originally recruited returned postal follow-up questionnaires at 4 years.